TOKU-E Talks
Find out what we're talking about
-
Posted on 02.07.22
The promise of Azlocillin and Cefotaxime for Lyme Disease
Lyme disease, caused by Borrelia burgdorferi, is one of most common vector-borne diseases. It is estimated that over 470,000 people are diagnosed and treated for the disease each year in the United States, based on insurance claims data...
-
Posted on 01.07.22
A powerful new class of enzyme blockers fight antibiotic resistance
Scientists at the University of Oxford have discovered a new potential combination with the power to reverse antimicrobial resistance (AMR) in bacteria that cause sepsis, pneumonia, and UTIs. AMR is a grave issue, and according to recent...
-
Posted on 12.15.21
A live look at TOKU-E: Our new company video
TOKU-E takes center stage in this one-minute animated video highlighting our company and what we can do for researchers around the globe. We invite you to click below to watch the video on our YouTube channel. For those interest...
-
Posted on 11.29.21
Join us at Cell Bio Virtual 2021
We will be hosting a virtual booth at Cell Bio Virtual. It is a joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO). It is the largest online forum for cell biologists. As Co...
-
Posted on 10.12.21
Effortless antimicrobial solution prep: Introducing ReadyMade™ Solutions
Let’s face it: Preparing antimicrobial stock solutions can be a pain. From sourcing the right product, finding the correct diluent, to weighing out powders, and filter-sterilizing... it all takes time that you could be spending el...